Exciting News from the Medicinal Cannabis Industry Association
At the 8th Annual General Meeting of Medicinal Cannabis Industry Australia (MCIA) held yesterday, the finalization of the merger with the Emerging Therapeutics Association of Australia (ETAA) was announced. This impactful move welcomes Ean Alexander (CEO, Altum), Matt Cantelo (CEO, ANTG), and Geoff Cockerill (incoming CEO, Vitura) to the MCIA Board. The expanded team will convene early in the new year to revisit the organisation’s strategies and set priorities that amplify support for our members.
During the AGM, Peter Koetsier stepped down as Chair and Director of MCIA. We extend our deepest gratitude to Peter for his exceptional leadership. A new Chair will be elected at the next Board meeting.
With highlights like the ongoing success of the Acannabis event and the $250,000 ATMAC grant from the Australian Government, the past year has been a strong one for MCIA. The ATMAC grant underscores the Government’s recognition of our industry’s potential and future growth opportunities.
The 2023/24 financial and annual reports are now available on the MCIA website.
As a member-driven organization, MCIA remains committed to building a professional and credible medicinal cannabis industry, both at home and on the global stage. Members enjoy direct involvement in shaping the focus areas that matter most to them.
If you’re not yet part of the MCIA, now’s the time to join a trusted and influential association driving the future of medicinal cannabis in Australia. Membership options are available for licensed and broader industry stakeholders.
Together, let’s continue to champion legitimacy, credibility, and recognition for the Australian sector!
– ENDS –
Download the PDF of this Media Release
MCIA Media Contact:
Patty Holmes
Executive Officer, MCIA
secretariat@mcia.org.au
About MCIA:
MCIA is the peak industry body and voice for Australia’s medicinal cannabis industry. Our focus is on building a legitimate industry that enhances wellbeing through facilitating access to quality Australian medicinal cannabis products for Australian and global patients. MCIA provides stewardship for an economically sustainable and socially responsible industry that is trusted and valued by patients, the medical community and governments. The Australian industry and its products are built on sound science and underpinned by industry processes and standards that ensure patients, the medical community and governments have confidence in the sector and its products.
About ACannabis:
ACannabis Conference and Exhibition is hosted annually by MCIA. Covering cultivation, manufacturing, products and patients, the conference examines innovations in research, compliance, regulations, education, and technology. ACannabis brings together participants from across the medicinal cannabis ecosystem, including policy makers, regulators, researchers, global leaders, healthcare professionals, patients and industry participants